|
1
|
Llovet JM, Burroughs A and Bruix J:
Hepatocellular carcinoma. Lancet. 362:1907–1917. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Worster DT, Schmelzle T, Solimini NL,
Lightcap ES, Millard B, Mills GB, Brugge JS and Albeck JG: Akt and
ERK control the proliferative response of mammary epithelial cells
to the growth factors IGF-1 and EGF through the cell cycle
inhibitor p57Kip2. Sci Signal. 5:ra192012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang J, Wang Q, Zhu N, Yu M, Shen B,
Xiang J and Lin A: Cyclic AMP inhibits JNK activation by
CREB-mediated induction of c-FLIPL and MKP-1, thereby
antagonizing UV-induced apoptosis. Cell Death Differ. 15:1654–1662.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yan J, Xiang J, Lin Y, Ma J, Zhang J,
Zhang H, Sun J, Danial NN, Liu J and Lin A: Inactivation of BAD by
IKK inhibits TNF-induced apoptosis independently of NF-κB
activation. Cell. 152:304–315. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
He G and Karin M: NF-kappaB and STAT3 –
key players in liver inflammation and cancer. Cell Res. 21:159–168.
2011. View Article : Google Scholar
|
|
6
|
Naugler WE, Sakurai T, Kim S, et al:
Gender disparity in liver cancer due to sex differences in
MyD88-dependent IL-6 production. Science. 317:121–124. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Balkwill F and Coussens LM: Cancer, an
inflammatory link. Nature. 431:405–406. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sakurai T, Itoh K, Higashisuji H,
Nonoguchi K, Liu Y, Watanabe H, Nakano T, Fukumoto M, Chiba T and
Fujita J: Cirp protects against tumor necrosis factor-α-induced
apoptosis via activation of extracellular signal-regulated kinase.
BBA-Mol Cell Res. 1763:290–295. 2005.
|
|
9
|
Suarez-Cuervo C, Harris KW, Kallman L,
Vaananen HK and Selander KS: Tumor necrosis factor-alpha induces
interleukin-6 production via extracellular-regulated kinase 1
activation in breast cancer cells. Breast Cancer Res Treat.
80:71–78. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Venables JP: Aberrant and alternative
splicing in cancer. Cancer Res. 64:7647–7654. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Srebrow A and Kornblihtt AR: The
connection between splicing and cancer. J Cell Sci. 119:2635–2641.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim E, Goren A and Ast G: Insights into
the connection between cancer and alternative splicing. Trends
Genet. 24:7–10. 2008. View Article : Google Scholar
|
|
13
|
Yoshida K, Sanada M, Shiraishi Y, et al:
Frequent pathway mutations of splicing machinery in myelodysplasia.
Nature. 478:64–69. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Quesada V, Ramsay AJ and Lopez-Otin C:
Chronic lymphocytic leukemia with SF3B1 mutation. N Engl J Med.
366:25302012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Karni R, de Stanchina E, Lowe SW, Sinha R,
Mu D and Krainer AR: The gene encoding the splicing factor SF2/ASF
is a proto-oncogene. Nat Struct Mol Biol. 14:185–193. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yea S, Narla G, Zhao X, Garg R, Tal-Kremer
S, Hod E, Villanueva A, Loke J, Tarocchi M, Akita K, Shirasawa S,
Sasazuki T, Martignetti JA, Llovet JM and Friedman SL: Ras promotes
growth by alternative splicing-mediated inactivation of the KLF6
tumor suppressor in hepatocellular carcinoma. Gastroenterology.
134:1521–1531. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Muñoz Ú, Puche JE, Hannivoort R, Lang UE,
Cohen-Naftaly M and Friedman SL: Hepatocyte growth factor enhances
alternative splicing of the Kruppel-like factor 6 (KLF6) tumor
suppressor to promote growth through SRSF1. Mol Cancer Res.
10:1216–1227. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tang G, Minemoto Y, Dibling B, Purcell NH,
Li Z, Karin M and Lin A: Inhibition of JNK activation through NF-κB
target genes. Nature. 414:313–317. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Anczuków O, Rosenberg AZ, Akerman M, Das
S, Zhan L, Karni R, Muthuswamy SK and Krainer AR: The splicing
factor SRSF1 regulates apoptosis and proliferation to promote
mammary epithelial cell transformation. Nat Struct Mol Biol.
19:220–228. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Geuking MB, Cahenzli J, Lawson MA, Ng DC,
Slack E, Hapfelmeier S, McCoy KD and Macpherson AJ: Intestinal
bacterial colonization induces mutualistic regulatory T cell
responses. Immunity. 34:794–806. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Panasyuk G, Nemazanyy I, Zhyvoloup A,
Filonenko V, Davies D, Robson M, Pedley RB, Waterfield M and Gout
I: mTORbeta splicing isoform promotes cell proliferation and
tumorigenesis. J Biol Chem. 284:30807–30814. 2009. View Article : Google Scholar : PubMed/NCBI
|
